GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Future 3-5Y EPS without NRI Growth Rate

C21 Investments (XCNQ:CXXI) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 07, 2025)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, C21 Investments's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of C21 Investments's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C21 Investments's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where C21 Investments's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

C21 Investments  (XCNQ:CXXI) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

C21 Investments Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of C21 Investments's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

C21 Investments Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
TSX:AVCN TSXV:VM NEOE:CBST XCNQ:LEEF XCNQ:RWB TSXV:ROMJ XCNQ:GWAY XCNQ:VEXT TSX:CWEB XCNQ:OPTI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
CXXIF:USA
Address
601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1
Website
https://www.cxxi.ca
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.
Executives
Todd Andrew Harrison Director
Bruce Macdonald Director
Sky Pinnick Director
Leonard Werden Director
Michael Starrett Kidd Director, Senior Officer

C21 Investments Headlines

No Headlines